Literature DB >> 29460111

The Changing Age of Individuals Seeking Presymptomatic Genetic Testing for Huntington Disease.

Melissa A Holman1, John Quillin2, Timothy P York2, Claudia M Testa3, Ami R Rosen4, Virginia W Norris3.   

Abstract

Huntington disease (HD) is a progressive neurodegenerative disorder. Presymptomatic genetic testing allows at-risk individuals to clarify their risk status. Understanding the characteristics and motivations of individuals seeking HD presymptomatic genetic testing better equips genetic counselors and other healthcare professionals to provide comprehensive and personalized care. The aims of this study were to (1) determine whether the average age when individuals seek presymptomatic HD genetic testing has decreased over time, (2) assess motivations for seeking testing, (3) explore whether there is a relationship between age and motivations, and (4) explore genetic counselors' perceptions of the shift in age. Data from the US HD testing centers (N = 4) were analyzed. A small but statistically significant decrease in age of individuals seeking presymptomatic testing was observed (p = 0.045). HD community members (N = 77) were surveyed regarding presymptomatic testing motivations. Younger individuals were more likely than older individuals to cite "To learn whether or not you would develop HD" and "To make choices about further education or a career" compared to older individuals (p < 0.05). Conversely, older individuals more frequently cited "To give children a better idea of their risk" (p < 0.002). Sixteen percent of genetic counselors surveyed (6/37) perceived a change in age of testing. All of these respondents had provided HD testing for ten or more years and anecdotally believed the age at testing has decreased over time. Study results help providers personalize counseling based on patient's age and serve as a starting point for more research into the relationship between age at testing and motivations for testing.

Entities:  

Keywords:  Age; Genetic counseling; Huntington disease; Motivations; Presymptomatic testing

Mesh:

Year:  2018        PMID: 29460111     DOI: 10.1007/s10897-018-0233-9

Source DB:  PubMed          Journal:  J Genet Couns        ISSN: 1059-7700            Impact factor:   2.537


  13 in total

1.  What were you thinking?: individuals at risk for Huntington Disease talk about having children.

Authors:  Kimberly A Quaid; Melinda M Swenson; Sharon L Sims; Joan M Harrison; Carol Moskowitz; Nonna Stepanov; Gregory W Suter; Beryl J Westphal
Journal:  J Genet Couns       Date:  2010-08-24       Impact factor: 2.537

2.  The utilization and outcome of diagnostic, predictive, and prenatal genetic testing for huntington disease in johannesburg, South Africa.

Authors:  Elaine B Sizer; Tabitha Haw; Tina-Marié Wessels; Jennifer G R Kromberg; Amanda Krause
Journal:  Genet Test Mol Biomarkers       Date:  2011-08-12

3.  Huntington disease: who seeks presymptomatic genetic testing, why and what are the outcomes?

Authors:  Tracey M Scuffham; John C MacMillan
Journal:  J Genet Couns       Date:  2014-01-08       Impact factor: 2.537

Review 4.  Milestones in huntington disease.

Authors:  Ira Shoulson; Anne B Young
Journal:  Mov Disord       Date:  2011-05       Impact factor: 10.338

5.  Acceptance of genetic testing in a general population: age, education and gender differences.

Authors:  A R Aro; A Hakonen; M Hietala; J Lönnqvist; P Niemelä; L Peltonen; P Aula
Journal:  Patient Educ Couns       Date:  1997 Sep-Oct

6.  Experiences of teens living in the shadow of Huntington Disease.

Authors:  Kathleen J H Sparbel; Martha Driessnack; Janet K Williams; Debra L Schutte; Toni Tripp-Reimer; Meghan McGonigal-Kenney; Lori Jarmon; Jane S Paulsen
Journal:  J Genet Couns       Date:  2008-03-18       Impact factor: 2.537

7.  Predictive genetic test decisions for Huntington's disease: context, appraisal and new moral imperatives.

Authors:  Sandra D Taylor
Journal:  Soc Sci Med       Date:  2004-01       Impact factor: 4.634

8.  "Holding your breath": interviews with young people who have undergone predictive genetic testing for Huntington disease.

Authors:  Rony E Duncan; Lynn Gillam; Julian Savulescu; Robert Williamson; John G Rogers; Martin B Delatycki
Journal:  Am J Med Genet A       Date:  2007-09-01       Impact factor: 2.802

9.  Late-onset Huntington's disease: diagnostic and prognostic considerations.

Authors:  Georgios Koutsis; Georgia Karadima; Athina Kladi; Marios Panas
Journal:  Parkinsonism Relat Disord       Date:  2014-03-27       Impact factor: 4.891

10.  Fifteen years of experience in predictive testing for Huntington disease at a single testing center in Victoria, Australia.

Authors:  M Kaye Trembath; Roslyn J Tassicker; Veronica R Collins; Sue Mansie; Leslie J Sheffield; Martin B Delatycki
Journal:  Genet Med       Date:  2006-11       Impact factor: 8.822

View more
  2 in total

1.  Predictive testing for Huntington disease over 24 years: Evolution of the profile of the participants and analysis of symptoms.

Authors:  Francis Ramond; Isabelle Quadrio; Laurence Le Vavasseur; Hélène Chaumet; Fabrice Boyer; Muriel Bost; Elisabeth Ollagnon-Roman
Journal:  Mol Genet Genomic Med       Date:  2019-08-22       Impact factor: 2.183

2.  Confidential genetic testing and electronic health records: A survey of current practices among Huntington disease testing centers.

Authors:  Celeste C Eno; Stacey K Barton; Naghmeh Dorrani; Stephen D Cederbaum; Joshua L Deignan; Wayne W Grody
Journal:  Mol Genet Genomic Med       Date:  2019-11-07       Impact factor: 2.183

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.